GIVINOSTAT (Duvyzat)

Clinical Indication

For the treatment of Duchenne Muscular Dystrophy.

Comments

Via the Early Access Programme only

Date of classification

February 2025

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.